lobbying_activities: 3340766
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3340766 | 6e419229-281f-4547-a572-9754c46564df | Q1 | MEHLMAN CONSULTING, INC. | 284950 | WEDGEWOOD PHARMACY LLC | 2025 | first_quarter | PHA | Issues related to animal drug compounding. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2025-04-17T12:58:11-04:00 |